UTAH MEDICAL PRODUCTS, INC. CONSOLIDATED CONDENSED STATEMENT OF CASH FLOW - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income	$ 3,140	$ 3,139
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation	175	179
Amortization	1,630	1,271
Provision for (recovery of) losses on accounts receivable	(14)	0
Amortization of Right of Use Assets	9	10
Deferred income taxes	(97)	(142)
Stock-based compensation expense	23	28
Tax benefit attributable to exercise of stock options	3	13
Changes in operating assets and liabilities:
Accounts receivable and other receivables	261	(940)
Inventories	158	(2,255)
Prepaid expenses and other current assets	(12)	(23)
Accounts payable	(31)	1,868
Accrued expenses	429	212
Total adjustments	2,534	221
Net cash provided by operating activities	5,674	3,360
CASH FLOWS FROM INVESTING ACTIVITIES:
Property and equipment	(454)	(12)
Intangible assets	0	(21,000)
Net cash used in investing activities	(454)	(21,012)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from issuance of common stock - options	48	97
Common stock purchased and retired	(6,426)	0
Payment of dividends	(1,042)	(1,027)
Net cash used in financing activities	(7,420)	(930)
Effect of exchange rate changes on cash	(974)	135
Net decrease in cash and cash equivalents	(3,174)	(18,447)
Cash at beginning of period	42,787	51,112
Cash at end of period	39,613	32,665
Cash paid during the period for income taxes	285	406
Cash paid during the period for interest	$ 0	$ 0